SCHEMBL8553197

SCHEMBL8553197

O=C1CC([S+]([O-])Cc2ccccc2)N1CCOCCCCCCc1ccc(F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
KDM4E B2RXH2 1/20 0.40
SLC6A4 P31645 4/20 0.38
SLC6A3 Q01959 4/20 0.38
SLC6A2 P23975 3/20 0.38
MEN1 O00255 2/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.38
MAPK1 P28482 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8555803 0.94 HRH3 (0.41) SIGMAR1HRH3
SCHEMBL8772402 0.91 HTR2A (0.43) HTR2ACYP1A2CYP3A4CYP2D6KDM4E
SCHEMBL8549722 0.90 HRH3 (0.41) SLC6A4SLC6A3SLC6A2KCNH2SIGMAR1
SCHEMBL8554624 0.85 MAPT (0.39) KDM4EMEN1ALDH1A1KMT2AMAPT
SCHEMBL8439618 0.84 GSK3A (0.43) CYP1A2CYP3A4CYP2D6MEN1KMT2A
SCHEMBL8772475 0.83 FAAH (0.42) CYP1A2CYP3A4CYP2D6MEN1KMT2A
SCHEMBL8772495 0.81 GSK3A (0.41) HTR2AMEN1MAPK1KMT2ASMN1; SMN2
SCHEMBL8378712 0.81 DRD3 (0.39) HTR2ACYP2D6MEN1KMT2AKCNH2
SCHEMBL8772498 0.81 HTT (0.39) MEN1ALDH1A1KMT2ASMN1; SMN2TP53
SCHEMBL8552101 0.81 LTA4H (0.39) SLC6A3MEN1ALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997002242-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-01-23 WO claimed
EP-0840725-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-05-13 EP disclosed
WO-1997002242-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-01-23 WO disclosed